He has received a CAREER Award from the National Science Foundation, and in 2014, he was appointed one of six Presidential Scholars at the University of Utah. Might received his Ph.D. in Computer Science from Georgia Tech. His son, Bertrand, was the first patient ever discovered with a rare disorder known as N-Glycanase deficiency. Matt posted an essay online that catalyzed the creation of a patient community, the remarkable aftermath of which has been chronicled in publications such as The New Yorker and Der Spiegel.